Search Results
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by J Karmisholt in
Google Scholar
PubMed
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by S L Andersen in
Google Scholar
PubMed
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by I Bulow-Pedersen in
Google Scholar
PubMed
Search for other papers by A Krejbjerg in
Google Scholar
PubMed
Search for other papers by B Nygaard in
Google Scholar
PubMed
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by A Carlé in
Google Scholar
PubMed
radioiodine, in a subgroup of patients. Materials and methods The inclusion process, treatment modality, and description of remission and relapse have previously been published ( 13 , 14 ). We included patients with GH (total T3 above the upper limit
Search for other papers by Sébastien Verdickt in
Google Scholar
PubMed
Search for other papers by Falco Van Nes in
Google Scholar
PubMed
Search for other papers by Carolien Moyson in
Google Scholar
PubMed
Search for other papers by Toon Maes in
Google Scholar
PubMed
Search for other papers by Paul Van Crombrugge in
Google Scholar
PubMed
Search for other papers by Annick Van den Bruel in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
before administration of RAI. Table 1 Baseline patient characteristics prior to first radioiodine therapy. TPO Ab-positive ( n = 105) TPO Ab-negative ( n = 47) P value Female 77.1% (81) 70.2% (33) 0
Institute of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Search for other papers by Peter F Berglund in
Google Scholar
PubMed
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Gothenburg Centre for Person Centred-Care (GPCC), Göteborg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
. ( https://doi.org/10.1530/eje.0.1510549 ) 3 Berg G Michanek A Holmberg E & Nystrom E . Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study . Journal of Internal Medicine 1996 239 165 – 171 . ( https://doi.org/10
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Search for other papers by Agneta Lindo in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Örebro University Hospital, Örebro, Sweden
Search for other papers by Anne Breikert in
Google Scholar
PubMed
Thyroid Federation International, Kungsbacka, Sweden
Search for other papers by Peter Lakwijk in
Google Scholar
PubMed
Swedish Thyroid Association, Stockholm, Sweden
Search for other papers by Christin Lundberg in
Google Scholar
PubMed
Swedish Thyroid Association, Stockholm, Sweden
Search for other papers by Katarina Lunner in
Google Scholar
PubMed
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Sweden and Wallenberg Center for Molecular and Translational Medicine, Västra Götaland Region, Göteborg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
drugs, surgery, or radioiodine: results from a prospective, randomized study . Thyroid 1998 8 653 – 659 . ( https://doi.org/10.1089/thy.1998.8.653 ) 16 van Kinschot CMJ Soekhai VR de Bekker-Grob EW Visser WE Peeters RP van Ginhoven TM
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Han Chen in
Google Scholar
PubMed
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
Thyrotoxicosis signs, symptomatic ophthalmopathy, and acromegaly 8.1 N/A ATD, pituitary irradiation, propranolol, radioiodine therapy, cortisone Recurrent hyperthyroidism several times, intermittent ATD treatment, TSH levels at or below detectable limits
Search for other papers by Thea Riis in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Thomas Heiberg Brix in
Google Scholar
PubMed
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
increased cancer risk in hyperthyroid patients could be mediated or modified by the treatment modality (anti-thyroid drugs, radioiodine, and surgery). Very few studies, if any, have reported treatment-specific risk estimates for cancer in hyperthyroid
Search for other papers by Stefan Matei Constantinescu in
Google Scholar
PubMed
Search for other papers by Julien Hospel in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
Search for other papers by Maria-Cristina Burlacu in
Google Scholar
PubMed
-up or insufficient follow-up, 17 patients for stopping medical treatment or receiving another treatment (radio-iodine or thyroidectomy) before having reached 12 months of treatment, and 13 for occurrence of pregnancy. The final analysis included 136
Search for other papers by Bruno Bouça in
Google Scholar
PubMed
Search for other papers by Ana Cláudia Martins in
Google Scholar
PubMed
Search for other papers by Paula Bogalho in
Google Scholar
PubMed
Search for other papers by Lídia Sousa in
Google Scholar
PubMed
Search for other papers by Tiago Bilhim in
Google Scholar
PubMed
Search for other papers by Filipe Veloso Gomes in
Google Scholar
PubMed
Search for other papers by Élia Coimbra in
Google Scholar
PubMed
Search for other papers by Ana Agapito in
Google Scholar
PubMed
Search for other papers by José Silva-Nunes in
Google Scholar
PubMed
, and nephrology teams – was held to assess definitive therapeutic possibilities. Radioiodine therapy was ruled out due to his high urinary iodide and salvage thyroidectomy was declined in face of patient’s cardiac condition and severe thyrotoxicosis
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Department of Pedagogical, Curricular and Professional Studies, Faculty of Education, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Simon Skau in
Google Scholar
PubMed
Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
G . Graves´disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or sugery . Thyroid 2005 15 1279 – 1286 . ( https://doi.org/10.1089/thy.2005.15.1279 ) 6 Cramon P Winther KH
Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed
Search for other papers by Grigoris Effraimidis in
Google Scholar
PubMed
the case of thyrotoxicosis with hyperthyroidism include antithyroid drugs, radioiodine ablation, or thyroidectomy and depend on individual patient characteristics and preferences ( 5 , 66 ). However, there is limited evidence regarding the optimal TSH